UK Housebuilding Sector in 3Q 2018… …trains, cows and beyond

The wit of Mauricio Pochettino

“It’s like the cow that every single day during 10 years sees the train crossing in front of it at the same time. And if you ask the cow what time is the train going to come, it’s not going to have the right answer. In football it’s the same”.
Such was the Delphic comment from Tottenham Hotspur’s Argentinian Manager in September coming off back-to-back losses in the Premier League.
By way of elucidation, too, Pochettino added: “experience on its own is not going to help you in the future”.

Isn’t it the same in the beautiful game of Housebuilding in the 2018-19 season?

Share on:

Written by: Charlotte Edwards

Find more news, interviews, share price & company profile here for:

Hardman & Co

Latest Company News

Fidelity Asian Values gains on significant China exposure (LON: FAS)

The Trust’s NAV rose by 1.8% for the 12 months to 31 May 2025, outperforming its reference index, which declined 0.6%. Strong stock selection, particularly in China, materials, and technology, contributed to gains, while overweight positions in Indonesian small caps detracted.

Emerging markets fund FEML rises on trade and AI optimism

Fidelity Emerging Markets gained in May, supported by easing trade tensions and investor enthusiasm for AI. The portfolio outperformed the index, with strong stock picking in materials and consumer discretionary sectors.

Pharos Energy CEO and CFO increase shareholdings

Pharos Energy plc announced that CEO Katherine Roe and CFO Sue Rivett purchased shares on 27 June 2025 at £0.21266 per share under existing trading plans.

TEAM Plc grows revenue and client assets ahead of UCITS fund launch

TEAM plc reported interim revenue growth to £5.8m and a rise in client assets to £1.112bn for HY25. The Group reduced annual operating costs by £668k and expanded its international advisory network to 59 advisers.

Aptamer advances liver fibrosis therapy with targeted gene delivery

Aptamer Group has identified a novel target using its Optimer® platform to deliver gene therapy directly to liver scarring cells.

SAE Renewables advances battery projects and marks 10 years on AIM

SAE Renewables reported steady progress in 2024, securing full ownership of its 240MWh AW1 battery project and submitting plans for a 1,200MWh system in Scotland. Revenues reached £14.4m, with EBITDA at £7.9m.